Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Rothweiler

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Current Issues in Molecular Biology|October 26, 2021
A Potential Role of the CD47/SIRPalpha Axis in COVID-19 PathogenesisKatie-May McLaughlin, Denisa Bojkova, Joshua D Kandler, et al.
British Journal of Cancer|September 18, 2023
Increased MCL1 dependency leads to new applications of BH3-mimetics in drug-resistant neuroblastomaMaureen Jacob, Sara Wiedemann, Daniela Brücher, et al.
Journal for Immunotherapy of Cancer|July 7, 2025
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapyLisa Marie Reindl, Lida Jalili, Tobias Bexte, et al.
Cell Death Discovery|March 19, 2026
Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative propertiesDenisa Bojkova, Katja Steinhorst, Marco Bechtel, et al.
Virulence|December 25, 2019
The <i>Acinetobacter</i> trimeric autotransporter adhesin Ata controls key virulence traits of <i>Acinetobacter baumannii</i>Marko Weidensdorfer, Masahito Ishikawa, Katsutoshi Hori, et al.
Cancers|June 2, 2021
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile CancerAnita Thomas, Sascha Reetz, Philipp Stenzel, et al.
Cancers|April 12, 2022
Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile CancerAnita Thomas, Kimberly Sue Slade, Roman A Blaheta, et al.
Molecular Cancer|May 28, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemiaShakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Research Square|May 4, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemiaShakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Scientific Reports|February 4, 2015
Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screenMartin Michaelis, Bishr Agha, Florian Rothweiler, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Current Issues in Molecular Biology|October 26, 2021
A Potential Role of the CD47/SIRPalpha Axis in COVID-19 PathogenesisKatie-May McLaughlin, Denisa Bojkova, Joshua D Kandler, et al.
British Journal of Cancer|September 18, 2023
Increased MCL1 dependency leads to new applications of BH3-mimetics in drug-resistant neuroblastomaMaureen Jacob, Sara Wiedemann, Daniela Brücher, et al.
Journal for Immunotherapy of Cancer|July 7, 2025
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapyLisa Marie Reindl, Lida Jalili, Tobias Bexte, et al.
Cell Death Discovery|March 19, 2026
Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative propertiesDenisa Bojkova, Katja Steinhorst, Marco Bechtel, et al.
Virulence|December 25, 2019
The <i>Acinetobacter</i> trimeric autotransporter adhesin Ata controls key virulence traits of <i>Acinetobacter baumannii</i>Marko Weidensdorfer, Masahito Ishikawa, Katsutoshi Hori, et al.
Cancers|June 2, 2021
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile CancerAnita Thomas, Sascha Reetz, Philipp Stenzel, et al.
Cancers|April 12, 2022
Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile CancerAnita Thomas, Kimberly Sue Slade, Roman A Blaheta, et al.
Molecular Cancer|May 28, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemiaShakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Research Square|May 4, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemiaShakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Scientific Reports|February 4, 2015
Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screenMartin Michaelis, Bishr Agha, Florian Rothweiler, et al.
Pageof 6